The content highlights key areas of focus in enterprise taxonomy, including professional development, population and public health, quality care, patient safety, and workforce care. It also mentions node settings related to excluding certain elements from the Accelerate RSS feed.
AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B
AstraZeneca has acquired exclusive global rights to develop and commercialize Dizal Pharmaceutical’s marketed lung cancer drug Zegfrovy® (sunvozertinib), through an agreement that could generate up to
